Rephonic
Artwork for The Future of HIV Care

The Future of HIV Care

TheBodyPro
HIV
HIV Care
Prep
Lenacapivir Prep
IAS Conference
Antiretroviral Therapy
Artificial Intelligence
HIV/AIDS
JAMA Network Open
New York
Refugees and Immigrants
Patient-Provider Trust
Medical Education
Stigma and Discrimination
Health Equity
Long-Acting Injectables
Chatbots
PEPFAR Funding Cuts
Denver Principles
Wellness Equity Alliance

Science is restless. It's always seeking, always exploring, always striving to answer new questions and build off the knowledge it has already gained. In HIV, we've spent decades refining our understanding of the virus and its complex web of intersections with our bodies and our societies. Yet we constantly strive to learn more, and to create ever-more-effective means by which we can prevent HIV t... more

PublishesMonthlyEpisodes41Founded4 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for The Future of HIV Care

Latest Episodes

After years of relatively little movement on the HIV treatment front, we're entering a new period of activity, as fresh FDA drug approvals begin to roll in and the research pipeline grows more intriguing. Longtime clinician-researcher Joel Gallant, M... more

Demetre Daskalakis, M.D., M.P.H., has returned to his roots: He's the new chief medical officer in town at Callen-Lorde, a widely respected, LGBTQ-centric HIV and health care institution in New York City. He joins the podcast to discuss the extent to... more

Newly appointed IDSA CEO (and former NIAID Director) Jeanne Marrazzo, M.D., M.P.H., joins us this month to discuss a wealth of important topics that stand at the intersection of HIV research, clinical care, and policy/politics. We touch on highlights... more

We welcome Oni Blackstock, M.D., M.H.S., to our miniseries of interviews with people who are leading some of the big conversations we're having as a health care community during a time of great change, and great strain, in HIV care provision within t... more

Regardless of your specific role in HIV care, you are almost certainly feeling the deeply challenging moment we face as science-respecting, empathetic human beings. But even as the U.S. response to HIV is persistently undermined by our own federal go... more

Each year on TheBodyPro, David Alain Wohl, M.D., of the University of North Carolina summarizes and analyzes the 10 new studies and noteworthy events that he feels are most likely to have a palpable impact on the way we approach HIV prevention, treat... more

Whether we think about it with excitement or fear (or both), AI has become a part of our daily lives — and, increasingly, it's a force we need to consider in HIV care provision. How can we best adapt to meet the moment? This month, we talk with Sean ... more

This month, we're slicing up a feast of guidance and information on HIV treatment switching in the setting of viral suppression. ART, after all, is not a "set it and forget it" proposition: Even when viral load is persistently undetectable, patients ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

National HIV Curriculum Podcast
National HIV Curriculum PodcastNational HIV Curriculum
Infectious Disease Puscast
Infectious Disease PuscastVincent Racaniello
The Daily
The DailyThe New York Times
Pivot
PivotNew York Magazine

Recent Guests

Joel Gallant
Longtime HIV researcher, clinician, and academic leader; Senior Medical Advisor for Access Research Group (AXCES)
Episode: Joel Gallant: Where Will Antiretroviral Therapy Go Next?
Demetre Daskalakis
Chief Medical Officer at Callen-Lorde
Callen-Lorde LGBTQ Health Center
Episode: Demetre Daskalakis: Great HIV Care Is a Form of Resistance
Jeanne Marrazzo
Physician and researcher, director roles at IDSA and HIVMA
IDSA / HIVMA
Episode: Jeanne Marrazzo: "We Just Can't Stop"
Oni Blackstock
Clinician, founder of Health Justice
Health Justice
Episode: "What Matters to You?" How Oni Blackstock Practices Hope
Benjamin Young
HIV clinician, researcher, consultant
Wellness Equity Alliance; Johns Hopkins Center for Public Health and Human Rights; STMA; The Body Pro
Episode: Back to Basics
David Alain Wohl
HIV clinician researcher; Professor of Medicine, Division of Infectious Diseases, University of North Carolina
University of North Carolina
Episode: Top HIV Clinical Developments of 2025
Sean Young
Professor of Emergency Medicine and Informatics, UC Irvine; Executive Director of UC Irvine's Institute for Prediction Technology
University of California, Irvine
Episode: You Can't Spell AIDS Without AI
Brian Wood
HIV physician, researcher and clinical leader
University of Washington; Mountain West AIDS Education and Training Center; Madison Satellite Clinics
Episode: Antiretroviral Therapy Is Not a Rotisserie Chicken
Rageshri Dhairyawan
Clinician researcher; NHS consultant in sexual health and HIV medicine; Deputy Director of the SHARE Collaborative for Health Equity
Queen Mary University of London / SHARE Collaborative for Health Equity
Episode: We Hear, They Heal

Host

Myles Helfand
Host of The Future of HIV Care, with involvement across interview and production activities.

Talking Points

Recent interactions between the hosts and their guests.

We Hear, They Heal
Q: How does leadership influence the adoption of more humane care?
Leaders should present both data and patient stories to demonstrate where care is succeeding or failing, create safe spaces for frontline staff to speak up, and ensure listening and collaboration are embedded in the culture.
We Hear, They Heal
Q: Can you speak to the idea of 'acknowledgement' in HIV care and what it looks like in practice?
Acknowledge that patients come with social and practical struggles that affect treatment, then build space for their voices; ask open questions, listen without rushing to fix, and integrate the social context into care planning.
Joel Gallant: Where Will Antiretroviral Therapy Go Next?
Q: Can you talk about the current work at ACCESS and what milestones or drugs you're watching most closely?
Gallant describes ACCESS trials as aiming to simplify therapy for those with resistance and to extend long-acting options, including two-drug regimens like bigtagivir-ledocapivir, and emphasizes rapid-start principles and real-world applicability across diverse regimens.
Antiretroviral Therapy Is Not a Rotisserie Chicken
Q: How do you approach the deliberation process with the patient and within your mind?
Focus on maintaining viral suppression, minimizing short- and long-term toxicity, aligning with patient goals, and recognizing that any switch carries some risk. Use a structured discussion, involve the multidisciplinary team, and ensure close follow-up after a switch to catch issues early.
Antiretroviral Therapy Is Not a Rotisserie Chicken
Q: What are the reasons to switch ART in a setting of viral suppression?
Reasons include simplifying regimens (fewer pills), reducing side effects and long-term toxicity, reducing drug interactions, addressing specific patient goals (weight, travel, stigma), and considering new regimens like long-acting injectables, all while weighing costs and access.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Future of HIV Care

What is The Future of HIV Care about and what kind of topics does it cover?

The show consistently centers HIV care evolution, practical clinical decision-making, and health equity, with episodes dissecting advances in antiretroviral therapy, long-acting regimens, PrEP developments, and the policy and funding environments that shape real-world access. Conversations frequently pair clinician-researchers with public health leaders to explore how innovations translate from trials to clinics and communities, while underscoring patient-centered care, trust-building, and equity across diverse populations. Noteworthy traits include a strong emphasis on practical tools for clinicians (switching regimens, implementing long-acting therapies, navigating guidelines), a willingness to tackle political and funding challenges, and... more

Where can I find podcast stats for The Future of HIV Care?

Rephonic provides a wide range of podcast stats for The Future of HIV Care. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Future of HIV Care and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Future of HIV Care get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Future of HIV Care, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Future of HIV Care?

Rephonic provides comprehensive predictive audience data for The Future of HIV Care, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Future of HIV Care have?

To see how many followers or subscribers The Future of HIV Care has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Future of HIV Care?

These podcasts share a similar audience with The Future of HIV Care:

1. National HIV Curriculum Podcast
2. Infectious Disease Puscast
3. The Daily
4. Pivot
5. Up First from NPR

How many episodes of The Future of HIV Care are there?

The Future of HIV Care launched 4 years ago and published 41 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Future of HIV Care?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Future of HIV Care?

Rephonic pulls ratings and reviews for The Future of HIV Care from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Future of HIV Care?

Rephonic provides full transcripts for episodes of The Future of HIV Care. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Future of HIV Care?

Recent guests on The Future of HIV Care include:

1. Joel Gallant
2. Demetre Daskalakis
3. Jeanne Marrazzo
4. Oni Blackstock
5. Benjamin Young
6. David Alain Wohl
7. Sean Young
8. Brian Wood

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days